Publications by authors named "Hava Ben-David"

Claim this Profile
T
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation.
Sara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas, Denise Kviatcovsky, Eyal Weinstock, Hava Ben-David

Cell· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 2 is overexpressed in Familial Mediterranean fever patients and is inhibited by colchicine treatment.
Hava Ben-David, Avi Livneh, Merav Lidar, Olga Feld, Souad Haj Yahia

Best Pract Res Clin Rheumatol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide.
Smadar Lapter, Hava Ben-David, Amir Sharabi, Heidy Zinger, Alona Telerman

Immunology· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.
Hava Ben-David, Amir Sharabi, Reshmi Parameswaran, Heidy Zinger, Edna Mozes

Immunology· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.
Reshmi Parameswaran, Hava Ben David, Amir Sharabi, Heidy Zinger, Edna Mozes

Clin Immunol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse model.
Amir Sharabi, Dror Luger, Hava Ben-David, Molly Dayan, Heidey Zinger

J Immunol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand.
Hava Ben-David, Amir Sharabi, Molly Dayan, Michael Sela, Edna Mozes

Proc Natl Acad Sci U S A· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses.
Hava Ben-David, Badiga Venkata Aruna, Rony Seger, Michael Sela, Edna Mozes

Proc Natl Acad Sci U S A· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
Badiga Venkata Aruna, Hava Ben-David, Michael Sela, Edna Mozes

Immunology· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis.
Hava Ben-David, Michael Sela, Edna Mozes

Proc Natl Acad Sci U S A· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis